These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36638064)

  • 21. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 22. CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.
    Kabwe JC; Sawada H; Mitani Y; Oshita H; Tsuboya N; Zhang E; Maruyama J; Miyasaka Y; Ko H; Oya K; Ito H; Yodoya N; Otsuki S; Ohashi H; Okamoto R; Dohi K; Nishimura Y; Mashimo T; Hirayama M; Maruyama K
    Respir Res; 2022 Apr; 23(1):87. PubMed ID: 35395852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
    Wong WK; Knowles JA; Morse JH
    Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis.
    Crosby A; Soon E; Jones FM; Southwood MR; Haghighat L; Toshner MR; Raine T; Horan I; Yang P; Moore S; Ferrer E; Wright P; Ormiston ML; White RJ; Haight DA; Dunne DW; Morrell NW
    Am J Respir Crit Care Med; 2015 Dec; 192(11):1355-65. PubMed ID: 26308618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of bone morphogenetic protein receptor axis during HIV-1 and cocaine-mediated pulmonary smooth muscle hyperplasia: implications for HIV-related pulmonary arterial hypertension.
    Dalvi P; O'Brien-Ladner A; Dhillon NK
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2585-95. PubMed ID: 24008158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
    Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
    Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
    Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension.
    Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC
    Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations.
    Dunmore BJ; Drake KM; Upton PD; Toshner MR; Aldred MA; Morrell NW
    Hum Mol Genet; 2013 Sep; 22(18):3667-79. PubMed ID: 23669347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Bisserier M; Mathiyalagan P; Zhang S; Elmastour F; Dorfmüller P; Humbert M; David G; Tarzami S; Weber T; Perros F; Sassi Y; Sahoo S; Hadri L
    Circulation; 2021 Jul; 144(1):52-73. PubMed ID: 34078089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
    Ormiston ML; Godoy RS; Chaudhary KR; Stewart DJ
    Circ Res; 2019 Mar; 124(6):822-824. PubMed ID: 30870124
    [No Abstract]   [Full Text] [Related]  

  • 34. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.
    Davies RJ; Holmes AM; Deighton J; Long L; Yang X; Barker L; Walker C; Budd DC; Upton PD; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L604-15. PubMed ID: 22227206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Bone Morphogenetic Protein Receptor Type 2 (
    Devendran A; Kar S; Bailey R; Trivieri MG
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice.
    Mushaben EM; Hershey GK; Pauciulo MW; Nichols WC; Le Cras TD
    PLoS One; 2012; 7(3):e32468. PubMed ID: 22427841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.
    Nishihara A; Watabe T; Imamura T; Miyazono K
    Mol Biol Cell; 2002 Sep; 13(9):3055-63. PubMed ID: 12221115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension.
    Andruska A; Ali MK; Spiekerkoetter E
    Am J Respir Cell Mol Biol; 2020 Aug; 63(2):137-138. PubMed ID: 32339467
    [No Abstract]   [Full Text] [Related]  

  • 39. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Nadeau V; Bonnet S; Paulin R
    Circulation; 2019 Aug; 140(7):e286-e287. PubMed ID: 31403848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.